NOTV Stock Analysis: Buy, Sell, or Hold?
NOTV - Inotiv, Inc. Common Stock
$0.08
-0.02 (-15.89%)
▼
5d:
-33.25%
30d:
-72.79%
90d:
-79.52%
HOLD
MODERATE Confidence
Analysis Updated: Jun 10, 2026 12:00 AM ET
Earnings: Aug 05, 2026
Get Alerted When NOTV Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: NOTV shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: NOTV shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: NOTV is currently trading at $0.08, which is considered oversold relative to its 30-day fair value range of $0.11 to $0.28.
Technical Outlook: Technically, NOTV is in a downtrend. The price is currently testing key support at $0.08. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 15.9% recently.
Market Sentiment: NOTV has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $3.25 (+3967.6%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, NOTV is in a downtrend. The price is currently testing key support at $0.08. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 15.9% recently.
Market Sentiment: NOTV has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $3.25 (+3967.6%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$0.11 -
$0.28
Company Quality Score
53/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
52.6%
All Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-15.9%)
- BULLISH: Trading 3967.6% below Wall St target ($3.25)
- CAUTION: 5-day price weakness (-33.2%) - monitor closely
Trading Range Analysis
30-Day Trading Range
$0.11 -
$0.28
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$0.08
Resistance Level
$0.32
Current Trend
Downtrend
Technical data as of
Jun 9, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-0.04
Wall Street Target
$3.25
(+3967.6%)
Revenue Growth (YoY)
-5.4%
Profit Margin
-17.1%
Share & Embed Analysis
Last updated: July 02, 2026 9:43 PM ET
Data refreshes hourly during market hours. Next update: 10:43 PM
Data refreshes hourly during market hours. Next update: 10:43 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is NOTV showing a specific setup today?
Insider Activity (6 Months)
0
Buys
3
Sells
Net
INSIDERS SELLING
Recent Transactions
Beth A Taylor
SELL
2888 shares
2026-02-17
John E Sagartz
SELL
2119 shares
2026-02-17
Robert Jr. Leasure
SELL
16810 shares
2026-02-17
Top Rated Diagnostics & Research Stocks
Top-rated stocks in Diagnostics & Research by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
TMO
Thermo Fisher Scientific… |
STRONG BUY
31 analysts |
$599 | 64 BUY |
|
EXAS
EXACT Sciences Corporati… |
STRONG BUY
26 analysts |
$106 | 65 BUY |
|
DHR
Danaher Corporation |
STRONG BUY
25 analysts |
$242 | 64 BUY |
|
GH
Guardant Health Inc |
STRONG BUY
23 analysts |
$144 | 61 BUY |
|
NTRA
Natera Inc |
STRONG BUY
21 analysts |
$260 | 54 HOLD |
